Literature DB >> 27116725

Vision Disturbances in Multiple Sclerosis.

Fiona Costello1.   

Abstract

Visual disturbances are frequently encountered in multiple sclerosis (MS), and include problems with how affected individuals see the world (afferent visual pathway symptoms) and how their eyes move together (efferent visual pathway disorders). Optic neuritis is the most common afferent visual pathway manifestation of MS, from which visual recovery is often incomplete. Visual field defects caused by lesions in the retrochiasmal or retrogeniculate regions of the afferent visual pathway also occur, albeit less frequently. Efferent visual pathway lesions causing ocular misalignment and nystagmus may lead to diplopia and oscillopsia, respectively. Vision loss has a major impact on perceptions regarding quality of life in MS. Therefore, it is important for clinicians to be able to identify and localize the underlying basis of visual disturbances to provide the best care possible for their patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27116725     DOI: 10.1055/s-0036-1579692

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  9 in total

1.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

2.  Histological and Top-Down Proteomic Analyses of the Visual Pathway in the Cuprizone Demyelination Model.

Authors:  Mohammed S M Almuslehi; Monokesh K Sen; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  J Mol Neurosci       Date:  2022-05-30       Impact factor: 2.866

3.  BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes.

Authors:  Meysam Yazdankhah; Sayan Ghosh; Peng Shang; Nadezda Stepicheva; Stacey Hose; Haitao Liu; Xitiz Chamling; Shenghe Tian; Mara L G Sullivan; Michael Joseph Calderon; Christopher S Fitting; Joseph Weiss; Ashwath Jayagopal; James T Handa; José-Alain Sahel; J Samuel Zigler; Paul R Kinchington; Donald J Zack; Debasish Sinha
Journal:  Autophagy       Date:  2021-01-19       Impact factor: 16.016

4.  Predictors of vision impairment in Multiple Sclerosis.

Authors:  Bernardo Sanchez-Dalmau; Elena H Martinez-Lapiscina; Irene Pulido-Valdeolivas; Irati Zubizarreta; Sara Llufriu; Yolanda Blanco; Nuria Sola-Valls; Maria Sepulveda; Ana Guerrero; Salut Alba; Magi Andorra; Anna Camos; Laura Sanchez-Vela; Veronica Alfonso; Albert Saiz; Pablo Villoslada
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 5.  Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review.

Authors:  Bernhard A Sabel; Josef Flammer; Lotfi B Merabet
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

6.  Cortical topological network changes following optic neuritis.

Authors:  Yael Backner; Ido Ben-Shalom; Joseph Kuchling; Nadja Siebert; Michael Scheel; Klemens Ruprecht; Alexander Brandt; Friedemann Paul; Netta Levin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-02

7.  Multiple Sclerosis Identification Based on Fractional Fourier Entropy and a Modified Jaya Algorithm.

Authors:  Shui-Hua Wang; Hong Cheng; Preetha Phillips; Yu-Dong Zhang
Journal:  Entropy (Basel)       Date:  2018-04-05       Impact factor: 2.524

8.  Visual oscillation effects on dynamic balance control in people with multiple sclerosis.

Authors:  Lara Riem; Scott A Beardsley; Ahmed Z Obeidat; Brian D Schmit
Journal:  J Neuroeng Rehabil       Date:  2022-08-17       Impact factor: 5.208

9.  Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis.

Authors:  Maria T Sekyi; Kelli Lauderdale; Kelley C Atkinson; Batis Golestany; Hawra Karim; Micah Feri; Joselyn S Soto; Cobi Diaz; Sung Hoon Kim; Marianne Cilluffo; Steven Nusinowitz; John A Katzenellenbogen; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2021-01-29       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.